Category: Evidence Briefs

Leucovorin & Autism – An Evidence Brief

New evidence brief finds leucovorin is not supported as a routine autism treatment Following its release of Autism: An Evidence Brief, the Australian Academy of Health and Medical Sciences has published a new evidence brief examining leucovorin (folinic acid) and autism. The brief finds that current evidence does not support the…

Measuring trust in health and medical science

Australians generally report high levels of trust in health and medical science, science and doctors. However, this trust is vulnerable and unevenly distributed – and does not always translate into engagement with evidence-based healthcare. A July 2026 AAHMS evidence brief examined what Australians say about their trust in health and…

Microplastics precaution and biomonitoring needed

From viral documentaries to scientific controversies – public debate around microplastics, forever chemicals and other contaminants has intensified in recent months. In this comprehensive evidence brief, the Australian Academy of Health and Medical Sciences outlines what we know, what we don’t know, and what Australia’s next steps should be. By…

Understanding Trust in the Health and Medical Sciences

Trust underpins every aspect of health and medical science (HMS), from how research is conducted and communicated, to how evidence is translated into health policy and clinical care. The Australian Academy of Health and Medical Sciences (AAHMS) has released the first in a series of policy explainers examining the concept…

Evidence Brief on Autism

The Australian Academy of Health and Medical Sciences has today released an evidence brief on autism. This evidence brief examines childhood autism, paracetamol and vaccination, and explains the science that demonstrates that there is no evidence for a causal link between autism and paracetamol, or autism and vaccines.